Metabolic disorders predict development of hypertension in normotensive Japanese subjects

Hypertension Research

Volumn 31, Issue 4, 2008, Pages 665-671

  Takase, Hiroyuki ^a   Dohi, Yasuaki ^b   Toriyama, Takayuki ^a   Okado, Tateo ^a   Tanaka, Satoru ^a   Sato, Koichi ^b   Kimura, Genjiro ^b  

^a Enshu Hospital   (Japan)

^b NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

Body mass index; High density lipoprotein cholesterol; Impaired glucose tolerance; Metabolic syndrome; Triglycerides

Indexed keywords

ANTIDIABETIC AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DRUG USE; DYSLIPIDEMIA; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INCIDENCE; JAPANESE; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; MULTIPLE REGRESSION; OBESITY; OBSERVATIONAL STUDY; PATHOGENESIS; PREDICTION; RISK ASSESSMENT;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE; BODY MASS INDEX; FEMALE; GLUCOSE INTOLERANCE; HUMANS; HYPERTENSION; INCIDENCE; JAPAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; REGRESSION ANALYSIS; RISK FACTORS;

EID: 44649096856     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.31.665     Document Type: Article

References (37)

1. Japanese Society of Hypertension: Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2004). Hypertens Res 2006; 29 (Suppl): S1-S105.
2. Burt VL, Whelton P, Roccella EJ, et al: Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995; 25: 305-313.
3. Vasan RS, Beiser A, Seshadri SR, et al: Residual lifetime risk for developing hypertension in middle-aged women and men: the Framingham Heart Study. JAMA 2002; 287: 1003-1010.
4. Ong KL, Cheung BM, Man YB, Lau CP, Lam KS: Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension 2007; 49: 69-75.
5. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Circulation 2002; 106: 3143-3421.
6. Ford ES, Giles WH, Mokdad AH: Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care 2004; 27: 2444-2449.
7. Hu G, Qiao Q, Tuomilehto J, Balkan B, Borch-Johnsen K, Pyorala K, DECODE Study Group: Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med 2004; 164: 1066-1076.
8. Tamaki S, Nakamura Y, Tabara Y, et al: Relationship between metabolic syndrome and Trp64Arg polymorphism of the P3-adrenergic receptor gene in a general sample: the Shigaraki Study. Hypertens Res 2006; 29: 891-896.
9. Mancia G, Bombelli M, Corrao G, et al: Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study: daily life blood pressure, cardiac damage, and prognosis. Hypertension 2007; 49: 40-47.
10. Ford ES: Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 2005; 28: 1769-1778.
11. Galassi A, Reynolds K, He J: Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med 2006; 119: 812-819.
12. Takeuchi H, Saitoh S, Takagi S, et al: Metabolic syndrome and cardiac disease in Japanese men: applicability of the concept of metabolic syndrome defined by the National Cholesterol Education Program-Adult Treatment Panel III to Japanese men - the Tanno and Sobetsu Study. Hypertens Res 2005; 28: 203-208.
13. Koji Y, Tomiyama H, Yamada J, et al: Relationship between Arterial Stiffness and the Risk of Coronary Artery Disease in Subjects with and without Metabolic Syndrome. Hypertens Res 2007; 30: 243-247.
14. Nishina M, Kikuchi T, Yamazaki H, Kameda K, Hiura M, Uchiyama M: Relationship among systolic blood pressure, serum insulin and leptin, and visceral fat accumulation in obese children. Hypertens Res 2003; 26: 281-288.
15. Ogawa Y, Kikuchi T, Nagasaki K, Hiura M, Tanaka Y, Uchiyama M: Usefulness of serum adiponectin level as a diagnostic marker of metabolic syndrome in obese Japanese children. Hypertens Res 2005; 28: 51-57.
16. Matsuzawa Y: The metabolic syndrome and adipocytokines. FEBS Lett 2006; 580: 2917-2921.
17. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K: Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 2006; 116: 1784-1792.
18. Chiba Y, Saitoh S, Takagi S, et al: Relationship between visceral fat and cardiovascular disease risk factors: the Tanno and Sobetsu study. Hypertens Res 2007; 30: 229-236.
19. Eguchi M, Tsuchihashi K, Saitoh S, et al: Visceral obesity in Japanese patients with metabolic syndrome: reappraisal of diagnostic criteria by CT scan. Hypertens Res 2007; 30: 315-323.
20. Kanai H, Tokunaga K, Fujioka S, Yamashita S, Kameda-Takemura KK, Matsuzawa Y: Decrease in intra-abdominal visceral fat may reduce blood pressure in obese hypertensive women. Hypertension 1996; 27: 125-129.
21. The Trials of Hypertension Prevention Collaborative Research Group: Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. The Trials of Hypertension Prevention, phase II. The Trials of Hypertension Prevention Collaborative Research Group. Arch Intern Med 1997; 157: 657-667.
22. Julius S, Nesbitt SD, Egan BM, et al, Trial of Preventing Hypertension (TROPHY) Study Investigators: Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med 2006; 354: 1685-1697.
23. Sesso HD, Wang L, Buring JE, Ridker PM, Gaziano JM: Comparison of interleukin-6 and C-reactive protein for the risk of developing hypertension in women. Hypertension 2007; 49: 304-310.
24. Wang TJ, Gona P, Larson MG, et al: Multiple biomarkers and the risk of incident hypertension. Hypertension 2007; 49: 432-438.
25. Panagiotakos DB, Pitsavos C, Yannakoulia M, Chrysohoou C, Stefanadis C: The implication of obesity and central fat on markers of chronic inflammation: the ATTICA study. Atherosclerosis 2005; 183: 308-315.
26. Shoelson SE, Lee J, Goldfine AB: Inflammation and insulin resistance. J Clin Invest 2006; 116: 1793-1801.
27. Saijo Y, Yoshioka E, Fukui T, Kawaharada M, Kishi R: Metabolic syndrome, C-reactive protein and increased arterial stiffness in Japanese subjects. Hypertens Res 2006; 29: 589-596.
28. Dohi Y, Takase H, Sato K, Ueda R: Association among C-reactive protein, oxidative stress, and traditional risk factors in healthy Japanese subjects. Int J Cardiol 2007; 115: 63-66.
29. Leitschuh M, Cupples LA, Kannel W, Gagnon D, Chobanian A: High-normal blood pressure progression to hypertension in the Framingham Heart Study. Hypertension 1991; 17: 22-27.
30. Vasan RS, Larson MG, Leip EP, Kannel WB, Levy D: Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet 2001; 358: 1682-1686.
31. Vasan RS, Larson MG, Leip EP, et al: Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001; 345: 1291-1297.
32. Stamler J, Stamler R, Neaton JD, et al: Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large cohorts of young adult and middle-aged men and women. JAMA 1999; 282: 2012-2018.
33. Kriketos AD, Robertson RM, Sharp TA, et al: Role of weight loss and polyunsaturated fatty acids in improving metabolic fitness in moderately obese, moderately hypertensive subjects. J Hypertens 2001; 19: 1745-1754.
34. Whelton PK, He J, Appel LJ, et al, National High Blood Pressure Education Program Coordinating Committee: Primary prevention of hypertension: clinical and public health advisory from the National High Blood Pressure Education Program. JAMA 2002; 288: 1882-1888.
35. Niskanen L, Laaksonen DE, Nyyssonen K, et al: Inflammation, abdominal obesity, and smoking as predictors of hypertension. Hypertension 2004; 44: 859-865.
36. Azadbakht L, Mirmiran P, Esmaillzadeh A, Azizi T, Azizi F: Beneficial effects of a Dietary Approaches to Stop Hypertension eating plan on features of the metabolic syndrome. Diabetes Care 2005; 28: 2823-2831.
37. Elmer PJ, Obarzanek E, Vollmer WM, et al, PREMIER Collaborative Research Group: Effects of comprehensive lifestyle modification on diet, weight, physical fitness, and blood pressure control: 18-month results of a randomized trial. Ann Intern Med 2006; 144: 485-495.